HRT FINANCIAL LP - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 72 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$19,000
-93.9%
14,817
-81.5%
0.00%
-100.0%
Q3 2021$311,000
-7.2%
80,216
-23.6%
0.00%
-33.3%
Q2 2021$335,000
+272.2%
104,946
+597.3%
0.00%
-78.6%
Q3 2018$90,00015,0500.01%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 169,578$222,0000.08%
Geneos Wealth Management Inc. 478,067$626,0000.03%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$16,0000.01%
Atria Wealth Solutions, Inc. 281,700$369,0000.01%
Vivaldi Capital Management LP 17,078$22,0000.01%
OSAIC HOLDINGS, INC. 1,284,481$1,684,0000.00%
Ameritas Advisory Services, LLC 45,302$59,0000.00%
CENTAURUS FINANCIAL, INC. 20,947$27,0000.00%
Summit Trail Advisors, LLC 23,855$31,0000.00%
WEDBUSH SECURITIES INC 27,998$37,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders